...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Metrics for evaluating patient navigation during cancer diagnosis and treatment : Crafting a policy-relevant research agenda for patient navigation in cancer care.
【24h】

Metrics for evaluating patient navigation during cancer diagnosis and treatment : Crafting a policy-relevant research agenda for patient navigation in cancer care.

机译：在癌症诊断和治疗过程中评估患者导航的指标：为癌症护理中的患者导航制定与政策相关的研究议程。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: Racial and ethnic minorities as well as other vulnerable populations experience disparate cancer-related health outcomes. Patient navigation is an emerging health care delivery innovation that offers promise in improving quality of cancer care delivery to these patients who experience unique health-access barriers. Metrics are needed to evaluate whether patient navigation can improve quality of care delivery, health outcomes, and overall value in health care during diagnosis and treatment of cancer. METHODS: Information regarding the current state of the science examining patient navigation interventions was gathered via search of the published scientific literature. A focus group of providers, patient navigators, and health-policy experts was convened as part of the Patient Navigation Leadership Summit sponsored by the American Cancer Society. Key metrics were identified for assessing the efficacy of patient navigation in cancer diagnosis and treatment. RESULTS: Patient navigation data exist for all stages of cancer care; however, the literature is more robust for its implementation during prevention, screening, and early diagnostic workup of cancer. Relatively fewer data are reported for outcomes and efficacy of patient navigation during cancer treatment. Metrics are proposed for a policy-relevant research agenda to evaluate the efficacy of patient navigation in cancer diagnosis and treatment. CONCLUSIONS: Patient navigation is understudied with respect to its use in cancer diagnosis and treatment. Core metrics are defined to evaluate its efficacy in improving outcomes and mitigating health-access barriers. Cancer 2011;117(15 suppl):3563-572. (c) 2011 American Cancer Society.
机译：背景：种族和少数族裔以及其他弱势人群经历了与癌症相关的不同健康后果。患者导航是一项新兴的医疗保健提供创新技术，它有望改善这些经历独特的健康获取障碍的患者的癌症医疗保健提供质量。需要度量标准来评估患者导航是否可以改善癌症诊断和治疗期间的护理质量，健康结果以及整体医疗保健价值。方法：通过搜索已发表的科学文献，收集有关检查患者导航干预措施的科学现状的信息。由美国癌症协会赞助的患者导航领导峰会的​​一部分，召集了一个由提供者，患者导航员和健康政策专家组成的焦点小组。确定了用于评估患者导航在癌症诊断和治疗中的功效的关键指标。结果：存在癌症护理所有阶段的患者导航数据;但是，对于在癌症的预防，筛查和早期诊断过程中的实施，文献更为可靠。关于癌症治疗期间患者导航的结果和功效的报道数据相对较少。提出了用于政策相关研究议程的度量，以评估患者导航在癌症诊断和治疗中的功效。结论：就其在癌症诊断和治疗中的应用而言，对患者导航的研究还很不足。定义了核心指标，以评估其在改善结果和减轻健康获得障碍方面的功效。 Cancer 2011; 117（15 suppl）：3563-572。 （c）2011年美国癌症协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号